Seqens Seqens

X

Find Radio Compass News for Atenolol

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
25
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - 100MG
  • TABLET;ORAL - 25MG
  • TABLET;ORAL - 50MG
  • TABLET;ORAL - 100MG;25MG
  • TABLET;ORAL - 50MG;25MG

https://recalls-rappels.canada.ca/en/alert-recall/recall-teva-atenolol-50mg-due-incorrect-product-image-label

HEALTH CANADA
21 Nov 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-2-2022-77418.pdf

FDA
02 Nov 2022

https://www.pharmaexcipients.com/news/compatibiliy-polymeric-excipients-atenolol/

PHARMAEXCIPIENTS
26 Nov 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215560

FDA
28 Oct 2021

https://www.livemint.com/companies/news/unichem-labs-receives-anda-approval-for-atenolol-and-chlorthalidone-tablets-11606639120793.html

J. Jagannath LIVEMINT
29 Nov 2020

https://www.fiercepharma.com/pharma/astrazeneca-hawks-suite-hyptertension-drugs-for-350m-latest-asset-sale

K. Blankenship FIERCE PHARMA
03 Mar 2020

https://endpts.com/after-a-brief-break-astrazeneca-is-back-at-divesting-handing-off-hypertension-meds-for-350m/

Amber Tong ENDPTS
28 Jan 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213136

FDA
27 Nov 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210028

FDA
13 Mar 2019

https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-March-29-2017-1490767993.pdf

FDA
29 Mar 2017

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/branded-heart-diabetes-drugs-much-costlier-than-generic-ones/articleshow/57576201.cms

ECONOMIC TIMES
10 Mar 2017

http://portal.anvisa.gov.br/noticias?p_p_id=101_INSTANCE_FXrpx9qY7FbU&p_p_col_id=column-2&p_p_col_pos=1&p_p_col_count=2&_101_INSTANCE_FXrpx9qY7FbU_groupId=219201&_101_INSTANCE_FXrpx9qY7FbU_urlTitle=liberado-lote-do-medicamento-atenolol&_101_INSTANCE_FXrpx9qY7FbU_struts_action=%2Fasset_publisher%2Fview_content&_101_INSTANCE_FXrpx9qY7FbU_assetEntryId=3037555&_101_INSTANCE_FXrpx9qY7FbU_type=content

ANVISA
04 Oct 2016

https://www.pharmacompass.com/pdf/news/pharmascience-recalls-one-lot-of-pms-atenolol-100mg-due-to-a-labelling-error-1470727024.pdf

HEALTHY CANADIANS
05 Aug 2016

http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/201616/anvisa+determina+interdicao++cautelar+de+lote+de+anti-hipertensivo+atenolol

ANVISA
12 May 2016

http://www.reuters.com/article/2015/11/13/us-health-access-heart-drugs-idUSKCN0T22ED20151113

Lisa Rapaport REUTERS
14 Nov 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY